Breast Cancer Research | Home page

Breast Cancer Research | Home page





Breast Cancer Research

Featured review: Cancer stem cell metabolism

Even though cancer is now viewed as a stem cell disease, there is still no consensus on the metabolic characteristics of these cells. This review by Maria Peiris-Pagès et al. summarizes the latest findings and discoveries on cancer stem cell metabolism.

Articles

• Recent
• Most accessed

Recent articles RSS

1. RESEARCH ARTICLE

   Prevalence of preterm, low birthweight, and small for gestational age delivery after breast cancer diagnosis: a population-based study

   Kristin Zeneé Black, Hazel B. Nichols, Eugenia Eng and Diane Louise Rowley

   Published on: 31 January 2017
2. RESEARCH ARTICLE

   Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program

   Merete Ellingjord-Dale, Linda Vos, Steinar Tretli, Solveig Hofvind, Isabel dos-Santos-Silva and Giske Ursin

   Published on: 23 January 2017
3. RESEARCH ARTICLE

   Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients

   Maeve Mullooly, Hannah P. Yang, Roni T. Falk, Sarah J. Nyante, Renata Cora, Ruth M. Pfeiffer, Derek C. Radisky, Daniel W. Visscher, Lynn C. Hartmann, Jodi M. Carter, Amy C. Degnim, Frank Z. Stanczyk, Jonine D. Figueroa, Montserrat Garcia-Closas, Jolanta Lissowska, Melissa A. Troester…

   Published on: 19 January 2017
4. RESEARCH ARTICLE

   Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells

   Craig E. Barcus, Kathleen A. O’Leary, Jennifer L. Brockman, Debra E. Rugowski, Yuming Liu, Nancy Garcia, Menggang Yu, Patricia J. Keely, Kevin W. Eliceiri and Linda A. Schuler

   Published on: 19 January 2017
5. RESEARCH ARTICLE

   PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression

   Vandna Shah, Salpie Nowinski, Dina Levi, Irek Shinomiya, Narda Kebaier Ep Chaabouni, Cheryl Gillett, Anita Grigoriadis, Trevor A. Graham, Rebecca Roylance, Michael A. Simpson, Sarah E. Pinder and Elinor J. Sawyer

   Published on: 17 January 2017

View all articles

Meet the Editor-in-Chief

Dr. Lewis A. Chodosh is a physician-scientist who received a BS in Molecular Biophysics and Biochemistry from Yale University, and MD from Harvard Medical School, and a PhD. in Biochemistry from M.I.T. in the laboratory of Dr. Phillip Sharp. He performed his clinical training in Internal Medicine and Endocrinology at the Massachusetts General Hospital, after which he was a postdoctoral research fellow with Dr. Philip Leder at Harvard Medical School. Dr. Chodosh joined the faculty of the University of Pennsylvania in 1994, where he is currently a Professor in the Departments of Cancer Biology, Cell & Developmental Biology, and Medicine. He serves as Chairman of the Department of Cancer Biology, Associate Director for Basic Science of the Abramson Cancer Center, and Director of Cancer Genetics for the Abramson Family Cancer Research Institute at the University of Pennsylvania. Additionally, he is on the scientific advisory board for the Harvard Nurses' Health Studies I and II. 

Dr. Chodosh's research focuses on genetic, genomic and molecular approaches to understanding breast cancer susceptibility and pathogenesis.

FEATURED THEMATIC SERIES - Lobular Breast Cancer

This special series takes a translational view of lobular breast cancer, from bedside to bench and back. The second most common breast cancer subtype, lobular breast cancer displays many unique molecular and clinical properties. Leaders in the field explore the molecular biology, pathology, risk factors, imaging, treatment and prognosis of this breast cancer.

Read the thematic series here